SC 13D Filing

Company

BIOCRYST PHARMACEUTICALS INC

Filed

February 16, 2018

Accession Number

0000930413-18-000522

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →